Clinical Trials in Denver

Showing 5001-5020 of 18,161 trials

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

NCT06634394

A multi-center, open-label, dose-finding study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML.

Acute Myeloid Leukemia (AML)

Aptevo Therapeutics39 participantsStarted Oct 2024

Denver, Colorado, United States • Miami, Florida, United States • Fairway, Kansas, United States +4 more locations

COMPLETEDPhase 45.4 miles

Adalimumab in JIA-associated Uveitis Stopping Trial

NCT03816397

The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).

UveitisJIA

Nisha Acharya87 participantsStarted Mar 2020

Sacramento, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +18 more locations

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Adalimumab in JIA-associated Uveitis Stopping Trial

Find Trials by Condition in Denver

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

STEM-Parkinson's Disease

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

A Study of SEA-CD40 Given With Other Drugs in Cancers

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Pediatric ACL: Understanding Treatment Options

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Trauma Informed Guilt Reduction Therapy

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)